Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Rofo ; 188(11): 1037-1044, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27299668

ABSTRACT

The new tracer Gallium-68 prostate-specific membrane antigen (Ga-68 PSMA) yields new promising options for the PET/CT diagnosis of prostate cancer (PCa) and its metastases. To overcome limitations of hybrid imaging, known from the use of choline derivatives, seems to be possible with the use of Ga-68 PSMA for PCa. The benefits of hybrid imaging with Ga-68 PSMA for PCa compared to choline derivatives shall be discussed in this article based on an overview of the current literature. Key Points: • Ga-68 PSMA PET/CT can achieve higher detection rates of PCa lesions than PET/CT performed with choline derivatives• The new tracer Ga-68 PSMA has the advantage of high specificity, independence of PSA-level and low nonspecific tracer uptake in surrounding tissue• The new tracer Ga-68 PSMA seems very suitable for MR-PET diagnostic Citation Format: • Schreiter V, Reimann C, Geisel D et al. Nuclear Medicine Imaging of Prostate Cancer. Fortschr Röntgenstr 2016; 188: 1037 - 1044.


Subject(s)
Edetic Acid/analogs & derivatives , Image Enhancement/methods , Magnetic Resonance Imaging/methods , Oligopeptides , Positron Emission Tomography Computed Tomography/methods , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/pathology , Gallium Isotopes , Gallium Radioisotopes , Humans , Male , Neoplasm Staging , Radiopharmaceuticals
2.
Nuklearmedizin ; 54(1): 31-5, 2015.
Article in English | MEDLINE | ID: mdl-25683108

ABSTRACT

UNLABELLED: The purpose of this study was to evaluate the reproducibility of a new software based analysing system for ventilation/perfusion single-photon emission computed tomography/computed tomography (V/P SPECT/CT) in patients with pulmonary emphysema and to compare it to the visual interpretation. PATIENTS, MATERIAL AND METHODS: 19 patients (mean age: 68.1 years) with pulmonary emphysema who underwent V/P SPECT/CT were included. Data were analysed by two independent observers in visual interpretation (VI) and by software based analysis system (SBAS). SBAS PMOD version 3.4 (Technologies Ltd, Zurich, Switzerland) was used to assess counts and volume per lung lobe/per lung and to calculate the count density per lung, lobe ratio of counts and ratio of count density. VI was performed using a visual scale to assess the mean counts per lung lobe. Interobserver variability and association for SBAS and VI were analysed using Spearman's rho correlation coefficient. RESULTS: Interobserver agreement correlated highly in perfusion (rho: 0.982, 0.957, 0.90, 0.979) and ventilation (rho: 0.972, 0.924, 0.941, 0.936) for count/count density per lobe and ratio of counts/count density in SBAS. Interobserver agreement correlated clearly for perfusion (rho: 0.655) and weakly for ventilation (rho: 0.458) in VI. CONCLUSIONS: SBAS provides more reproducible measures than VI for the relative tracer uptake in V/P SPECT/CTs in patients with pulmonary emphysema. However, SBAS has to be improved for routine clinical use.


Subject(s)
Image Interpretation, Computer-Assisted/methods , Multimodal Imaging/methods , Pulmonary Emphysema/diagnosis , Software , Tomography, Emission-Computed, Single-Photon/methods , Ventilation-Perfusion Ratio , Aged , Algorithms , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity , Software Validation
3.
Article in English | MEDLINE | ID: mdl-24382374

ABSTRACT

Aim: Pancreatic neuroendocrine tumors (PNETs) pose a diagnostic challenge with respect to the physiologic somatostatin receptor expression in the uncinate process representing a potential pitfall for receptor imaging with PET/CT. Methods: We identified 49 PNETs from a total of 316 consecutive [68Ga]DOTATOC PET/CT examinations for whom the detections rates of PET and multiphase contrast enhanced (CE-) CT could be retrospectively compared and 38 PNETs for which SUV max and SUV max target-to-liver ratios could be calculated for the tumors and the uncinate process. Results: The detection rate of PET (83.7%) was higher than of the different CT phases (arterial: 59.2%, P=0.017; portal-venous: 38.8%, P<0.001; venous: 46.9%, P=0.001; multiphase: 71.4%, P=0.286). Compared to the other method PET revealed 28.6% additional lesions and multiphase CE-CT 16.3%. The portal-venous phase revealed only lesions that were also detected in the arterial or venous phase. The detection rate for PNETs in the uncinate process (N.=9) was 66.7% for PET versus 55.6% for multiphase CE-CT. SUV max and SUV max target-to-liver ratios differed significantly (P<0.001) for PNETs (mean, range: SUV max,14.6, 1.4-69.3; SUV max target-to-liver ratio, 3.2, 0.69-23.1) and uncinate process (4.32, 0.8-13.5; 0.94, 0.51-1.56), however with a wide overlap. Conclusion: Patients with PNETs should undergo [68Ga]DOTATOC PET/CT with at least an arterial and venous phase CT scan. SUV max and SUV max target-to-liver ratios provide additional information but do no reliably separate PNETs from normal tracer uptake in the uncinate process.

4.
Cardiovasc Intervent Radiol ; 37(2): 445-50, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23839005

ABSTRACT

PURPOSE: This study was designed to evaluate the technical eligibility for magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment of women with symptomatic fibroids. METHODS: Technical eligibility for MRgFUS treatment without mitigation techniques was evaluated retrospectively in 783 premenopausal women (median age, 44.2 years) with symptomatic fibroids who applied for uterine artery embolization (UAE) at our institution from 2001 to 2012. Technical eligibility for MRgFUS was defined as primary study endpoint. Technical ineligibility was assessed on the basis of MRI criteria, such as bowel interposition/foreign material in the ultrasound beam path, more than five fibroids, distance from fibroid to sacral bone surface, fibroid size/shape, severe concomitant adenomyosis or extensive cutaneous scars in accordance to the US Food and Drug Administration approvals. Secondary study endpoint was defined as evaluation of the most frequent exclusion criteria and differences in technical eligibility for MRgFUS and UAE. RESULTS: On the basis of MRI, 38.9% of women who applied for UAE were found to be technically eligible for MRgFUS treatment without mitigation techniques. Most frequent reason for ineligibility was bowel interposition in the ultrasound beam path (60.4%). Differences in technical eligibility for MRgFUS (38.9%) and UAE (99.2%) were significant (P < 0.001). CONCLUSIONS: MRgFUS treatment is technically possible in up to 40% of women with symptomatic fibroids. The most frequent exclusion criterion is the presence of bowel in the ultrasound beam path.


Subject(s)
Leiomyoma/diagnosis , Leiomyoma/surgery , Magnetic Resonance Imaging/methods , Ultrasonic Surgical Procedures/methods , Uterine Neoplasms/diagnosis , Uterine Neoplasms/surgery , Adult , Age Factors , Aged , Cohort Studies , Female , Follow-Up Studies , Humans , Patient Selection , Postoperative Complications/epidemiology , Postoperative Complications/physiopathology , Retrospective Studies , Risk Assessment , Treatment Outcome
5.
Eur J Radiol ; 82(12): 2265-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24075785

ABSTRACT

OBJECTIVES: To compare the long-term outcome after uterine artery embolization (UAE) versus magnetic resonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids. METHODS: Seventy-seven women (median age, 39.3 years; range, 29.2-52.2 years) with symptomatic uterine fibroids, equally eligible for UAE and MR-g HIFU based on our exclusion criteria underwent treatment (UAE, N = 41; MR-g HIFU, N = 36) from 2002 to 2009 at our institution. Symptom severity (SS) and total health-related quality of life (Total HRQoL) scores were assessed by the uterine fibroid symptom and quality of life (UFS-QoL) questionnaire before treatment and at long-term follow-up after UAE (median 61.9 months) and after MR-g HIFU (median: 60.7 months). Re-intervention rates were assessed for each therapy and compared. RESULTS: Re-intervention was significantly lower after UAE (12.2%) than after MR-g HIFU (66.7%) at long-term follow-up (p<0.001). After UAE changes in SS (50 pre-treatment vs. 6.3 post-treatment) and Total HRQoL (57.8 pre-treatment vs. 100 post-treatment) were significantly better than changes in SS (42.2 pre-treatment vs. 26.6 post-treatment) and Total HRQoL score (66.4 pre-treatment vs. 87.9 post-treatment) after MR-g HIFU (p = 0.019 and 0.049 respectively). CONCLUSIONS: Improvement of SS and Total HRQoL scores was significantly better after UAE resulting in a significant lower re-intervention rate compared to MR-g HIFU.


Subject(s)
High-Intensity Focused Ultrasound Ablation/methods , Leiomyoma/pathology , Leiomyoma/therapy , Magnetic Resonance Imaging/methods , Uterine Artery Embolization/methods , Uterine Neoplasms/pathology , Uterine Neoplasms/therapy , Adult , Female , Humans , Longitudinal Studies , Middle Aged , Surgery, Computer-Assisted/methods , Treatment Outcome
6.
Rofo ; 185(4): 358-66, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23494503

ABSTRACT

PURPOSE: To investigate whether changes in hemodynamics induced by Valsalva maneuver can be exploited for detecting and characterizing breast lesions by optical mammography. MATERIALS AND METHODS: 30 women underwent optical imaging of the breast using a DYNOT 232 system and performing Valsalva maneuvers prior to biopsy. Changes in light absorption due to changes in oxyhemoglobin and deoxyhemoglobin concentrations were recorded volumetrically and in a time-resolved manner. The parameters full width at half maximum (FWHM), time to ten (TTT), and peak amplitude (PA) of the reconstructed concentration time curves yielded color-coded maps of the breast which were separately evaluated by two experienced readers for detection rate, degree of visibility, and detection of additional lesions. ROC analysis was performed with the evaluation results. RESULTS: 10 patients were excluded from analysis due to artifacts or inadequately performed Valsalva maneuver. The resulting 20 patients showed a clear increase in oxygenated and deoxygenated hemoglobin concentration after the onset of the Valsalva maneuver. ROC analysis yielded AUC values (0.393 - 0.779) that did not differ from random probabilities. The highest AUC values were obtained for FWHM (AUC: 0.779, detection rates [60 - 70 %], identification of additional lesions [55 - 70 %]). PA analysis had the highest detection rate (70 - 90 %) but also the highest identification of false-positive additional lesions (80 - 90 %). The concordance rates of the two readers for malignant lesions were satisfactory (0.524 - 1.0). CONCLUSION: Our study revealed susceptibility to artifacts and a large number of false-positive additional lesions, suggesting that the evaluation of hemodynamic changes after Valsalva maneuver by optical imaging is not a promising method.


Subject(s)
Breast Neoplasms/blood supply , Breast Neoplasms/diagnosis , Hemodynamics/physiology , Image Interpretation, Computer-Assisted/instrumentation , Image Interpretation, Computer-Assisted/methods , Imaging, Three-Dimensional/instrumentation , Imaging, Three-Dimensional/methods , Optical Imaging/instrumentation , Optical Imaging/methods , Spectroscopy, Near-Infrared/instrumentation , Spectroscopy, Near-Infrared/methods , Valsalva Maneuver/physiology , Breast/blood supply , Breast/pathology , Breast Neoplasms/pathology , Female , Hemoglobins/metabolism , Humans , Oxyhemoglobins/metabolism , Prospective Studies , Sensitivity and Specificity
7.
Cardiovasc Intervent Radiol ; 36(6): 1508-1513, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23456309

ABSTRACT

PURPOSE: To compare the rate of reintervention and midterm changes in symptom severity (SS) and Total health-related quality of life (HRQoL) scores after uterine artery embolization (UAE) and magnetic resonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids. METHODS: Eighty women (median age 38.3 years), equally eligible for MR-g HIFU and UAE who underwent one of both treatments between 2002 and 2009 at our institution, were included. The primary end point of the study was defined as the rate of reintervention after both therapies. The secondary outcome was defined as changes in SS and Total HRQoL scores after treatment. SS and Total HRQoL scores before treatment and at midterm follow-up (median 13.3 months) were assessed by the uterine fibroid symptom and quality-of-life questionnaire (UFS-QoL) and compared. RESULTS: The rate of reintervention was significantly lower after UAE than after MR-g HIFU (p = 0.002). After both treatments, SS and Total HRQoL scores improved significantly from baseline to follow-up (UAE: p < 0.001, p < 0.001; MR-g HIFU: p = 0.002, p < 0.001). Total HRQoL scores were significantly higher after UAE than after MR-g HIFU (p = 0.032). Changes in the SS scores did not differ significantly for both treatments (p = 0.061). CONCLUSION: UAE and MR-g HIFU significantly improved the health-related quality of life of women with symptomatic uterine fibroids. After UAE, the change in Total HRQoL score improvement was significantly better, and a significantly lower rate of reintervention was observed.


Subject(s)
High-Intensity Focused Ultrasound Ablation/methods , Leiomyoma/surgery , Magnetic Resonance Imaging/methods , Ultrasonography, Interventional/methods , Uterine Artery Embolization/methods , Uterine Neoplasms/surgery , Adult , Combined Modality Therapy/methods , Female , Humans , Quality of Life , Retreatment/statistics & numerical data , Severity of Illness Index , Surveys and Questionnaires , Treatment Outcome
9.
Rofo ; 184(1): 48-52, 2012 Jan.
Article in German | MEDLINE | ID: mdl-22161234

ABSTRACT

AIM: To evaluate the clinical response of uterine artery embolization (UAE) in women with symptomatic uterine adenomyosis by comparing health-related quality of life and symptom severity before and after UAE using a standardized questionnaire. MATERIAL AND METHODS: This longitudinal study at two time points included 17 patients with a median age of 47.1 years with symptomatic uterine adenomyosis (n = 7 pure adenomyosis; n = 10 with concomitant fibroids). The diagnosis was based on clinical symptoms and magnetic resonance imaging (MRI) criteria. Data on health-related quality of life and severity of symptoms before and after UAE were obtained by the standardized "Uterine Fibroid Symptom and Quality of Life" (UFS-QOL) questionnaire and correlated in the following. Treatment failure was defined as the need for a second invasive procedure because of recurrent symptoms or persistent symptoms after UAE. RESULTS: The median interval between the evaluation of the UFS-QOL questionnaire before and after UAE was 46.0 months. 70.6 % (12/17; 95 % confidence interval 44.0 %  - 88.6 %) of the patients had therapy response with a significant improvement of health-related quality of life and clinical symptoms (p-value = 0.002). The therapy failure rate was 29.4 % (5/17; 95 % confidence interval 11.4 %  - 56.0 %). One patient underwent dilatation and curettage and four patients underwent hysterectomy because of therapy failure. CONCLUSION: UAE to treat symptomatic adenomyosis uteri can significantly improve the health-related quality of life and clinical symptoms. However, therapy failure is possible in up to one-third of patients.


Subject(s)
Embolization, Therapeutic/methods , Endometriosis/therapy , Quality of Life , Uterine Diseases/therapy , Uterus/blood supply , Adult , Endometriosis/diagnosis , Female , Humans , Leiomyoma/blood supply , Leiomyoma/diagnosis , Leiomyoma/therapy , Magnetic Resonance Imaging, Interventional , Middle Aged , Psychometrics/statistics & numerical data , Reproducibility of Results , Retrospective Studies , Surveys and Questionnaires , Treatment Failure , Uterine Diseases/diagnosis , Uterine Neoplasms/blood supply , Uterine Neoplasms/diagnosis , Uterine Neoplasms/therapy
10.
Rofo ; 183(10): 956-63, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21972043

ABSTRACT

PURPOSE: To evaluate fast 3D near-infrared breast imaging using the optical contrast agent indocyanine green (ICG) for the detection and characterization of breast lesions. MATERIALS AND METHODS: 30 patients with suspicious breast lesions on mammography and/or ultrasound underwent fast 2 Hz 3D optical mammography before, during, and after administration of a 25 mg ICG bolus prior to needle biopsy. The bolus kinetics is analyzed using two perfusion parameters and a derived parameter: "peak amplitude" (PA), "time-to-peak" (TTP) and "peak-time grouped amplitude" (PTA). A receiver operating characteristic curve (ROC) analysis was performed to define a PTA cut-off for reader-independent differentiation of benign and malignant lesions. 8 patients had to be excluded from data analysis. Overall 14 breasts bearing a malignant lesion, 8 breasts bearing a benign lesion and 3 healthy breasts were analyzed. RESULTS: The cut-off-based PTA analysis allowed correct detection for 12 of 14 malignant lesions (tumor size: 8 - 80 mm; sensitivity = 85.7 %). Two malignant lesions were missed. In the benign study group only one fibroadenoma was detected (specificity = 87.5 %). The PTA values differed significantly between the benign group and the malignant group (Mann-Whitney U-test, p < 0.05). Breasts with malignant lesions showed higher peaks at early time-points in ICG perfusion. CONCLUSION: Early perfusion analysis of ICG-enhanced 3D fast optical mammography revealed different enhancement patterns for benign and malignant lesions. This approach might help with the detection of malignant breast lesions and the differentiation from benign lesions.


Subject(s)
Breast Neoplasms/diagnosis , Carcinoma, Ductal, Breast/diagnosis , Carcinoma, Intraductal, Noninfiltrating/diagnosis , Carcinoma, Lobular/diagnosis , Carcinoma/diagnosis , Contrast Media/administration & dosage , Diagnostic Imaging/instrumentation , Image Processing, Computer-Assisted/instrumentation , Imaging, Three-Dimensional/instrumentation , Indocyanine Green , Mammography/instrumentation , Tomography, Optical/instrumentation , Ultrasonography, Mammary/instrumentation , Adult , Aged , Biopsy, Needle , Breast/pathology , Breast Neoplasms/pathology , Carcinoma/pathology , Carcinoma, Ductal, Breast/pathology , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Lobular/pathology , Diagnosis, Differential , Equipment Design , Female , Fibroadenoma/diagnosis , Fibroadenoma/pathology , Fibrocystic Breast Disease/diagnosis , Fibrocystic Breast Disease/pathology , Humans , Middle Aged , Sensitivity and Specificity
11.
Rofo ; 183(7): 650-7, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21667423

ABSTRACT

PURPOSE: The DICOM standard supports both quantitative and qualitative lossy compression of mammograms.The purpose of this study was to investigate qualitative JPEG 2000 lossy compression and how different factors such as object thickness, radiation dose, and lossy compression levels affect image quality. MATERIALS AND METHODS: The CDMAM phantom Artinis 3.4 was radiographed with 4 different object thicknesses and 5 different doses. The images were compressed at 10 different compression levels. The image quality was assessed by the software interpolated IQFinv value. RESULTS: Lossy 90 resulted in 89 % data reduction, lossy 70 in 95 % data reduction and lossy 60 in 96 % data reduction. At higher compression levels (lossy 30), the resulting image quality ranged from 80 - 36 %, and at low compression levels (lossy 90), it ranged from 89 - 93 %. The object thickness was found to significantly interact with the compression level with regard to the resulting image quality: a higher object thickness resulted in increasingly poor image quality at increasing compression levels (p < 0.05). CONCLUSION: Higher qualitative JPEG 2000 compression levels contribute only little additional data reduction, while the resulting image quality cannot be reliably predicted. Factors affecting image quality such as radiation dose and object thickness should be taken into account when performing image compression. Large object thicknesses should be compressed with caution because the loss of image quality is greater when intelligent data compression algorithms are used.


Subject(s)
Data Compression/methods , Image Enhancement/methods , Image Processing, Computer-Assisted/methods , Mammography/methods , Phantoms, Imaging , Radiographic Image Enhancement/methods , Algorithms , Female , Humans , Sensitivity and Specificity
12.
Rofo ; 183(5): 448-55, 2011 May.
Article in English | MEDLINE | ID: mdl-21274828

ABSTRACT

PURPOSE: Paclitaxel-coated balloon catheters inhibit restenosis after coronary and peripheral angioplasty (PCI,PTA). The aim of this study was to investigate paclitaxel plasma levels and laboratory parameters following PTA with paclitaxel-coated balloons (PCB) in peripheral arteries. MATERIALS AND METHODS: This single treatment arm, multicenter study included 14 patients with Rutherford stage 1 - 5 with occlusions of up to 5 cm or ≥ 70 % diameter stenosis of the superficial femoral or popliteal arteries (SFA, PA). PTA was performed using up to three PCB catheters. The paclitaxel plasma levels and safety laboratory parameters were determined by collecting blood samples pre-intervention, immediately post-intervention, at 0.5, 1, 2, 4, 8, 24 hours and 1 and 4 weeks post-intervention (p. i.). Vital signs were monitored to assess clinical safety. RESULTS: PTA was performed successfully in all patients. Paclitaxel plasma levels were always below a level and duration known to cause systemic side effects. A mean peak paclitaxel plasma level (40 ng/ml) was reached immediately p. i. and decreased rapidly below detectable levels in more than half of the patients already 2 hours p. i. The paclitaxel plasma concentrations returned to values below detectable levels at 24 hours p. i. in all patients. Laboratory parameters and vital signs did not give any reason for safety concerns. No adverse events associated with balloon coating were observed. CONCLUSION: The results of 14 patients with peripheral arterial occlusive disease show no systemic bioavailability of paclitaxel > 24 hours after PTA with one or more PCB catheters, indicating that the PCB catheter is safe with regard to possible systemic effects.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/pharmacokinetics , Arterial Occlusive Diseases/blood , Arterial Occlusive Diseases/therapy , Catheterization/instrumentation , Coated Materials, Biocompatible , Drug Delivery Systems/instrumentation , Drug Delivery Systems/methods , Femoral Artery , Paclitaxel/administration & dosage , Paclitaxel/pharmacokinetics , Popliteal Artery , Aged , Antineoplastic Agents, Phytogenic/adverse effects , Biological Availability , Dose-Response Relationship, Drug , Equipment Safety , Female , Humans , Male , Metabolic Clearance Rate , Middle Aged , Paclitaxel/adverse effects
13.
Rofo ; 182(11): 965-72, 2010 Nov.
Article in German | MEDLINE | ID: mdl-20957594

ABSTRACT

PURPOSE: To investigate two event-oriented methods for evaluating patient satisfaction with radiological services like outpatient computed tomography (CT) examinations. MATERIALS AND METHODS: 159 patients (55% men, 45% women) were asked to complete a questionnaire to provide information about their satisfaction with their examination. At first, patients were asked to spontaneously recall notably positive and negative aspects (so-called "critical incidents", critical incident technique = CIT) of the examination. Subsequently a flow chart containing all single steps of the examination procedure was shown to all patients. They were asked to point out the positive and negative aspects they perceived at each step (so-called sequential incident technique = SIT). RESULTS: The CIT-based part of the questionnaire yielded 356 comments (183 positive and 173 negative), which were assigned to one of four categories: interaction of staff with patient, procedure and organization, CT examination, and overall setting of the examination. Significantly more detailed comments regarding individual aspects of the CT examination were elicited in the second part of the survey, which was based on the SIT. There were 1413 statements with a significantly higher number of positive comments (n = 939, 66%) versus negative comments (n = 474, 34%; p < 0.001). CONCLUSION: The critical and sequential incident techniques are suitable to measure the subjective satisfaction with the delivery of radiological services such as CT examinations. Positive comments confirm the adequacy of the existing procedures, while negative comments provide direct information about how service quality can be improved.


Subject(s)
Patient Satisfaction , Surveys and Questionnaires , Tomography, X-Ray Computed/standards , Adult , Aged , Aged, 80 and over , Ambulatory Care/standards , Data Collection/standards , Delivery of Health Care/standards , Female , Germany , Humans , Interview, Psychological , Male , Middle Aged , Prospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...